Review



human enos nos3 small interfering rna  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology human enos nos3 small interfering rna
    Figure 6. <t>eNOS</t> expression and NO production in EC. (a) Analysis of DAF-FM fluorescence intensity of primary ECs measured at 495 nm. Scatter dot plot shows the mean SD; n ¼ 3. **P < 0.005. (b) <t>NOS3</t> transcript amplification in primary ECs of Mmp14fl/fland Mmp14EC‒/‒ mice using S26 as control. Scatter dot plot shows the mean SD; n ¼ 9; *P < 0.05. (c) Primary ECs stained for eNOS (red) and nuclei (DAPI, blue). eNOS expression intensity was quantified. The scatter dot plot shows the mean SD. **P < 0.005. Bar ¼ 50 mm. (d) Quantitative analysis of eNOS and MMP14 expression in human melanoma. Intensities are arbitrarily set as þ (low), þþ (moderate), and þþþ (high). Graphs show the percentage of eNOS expression intensity in low, moderate, or high MMP14- expressing vessels. Arrowheads indicate representative vessels. n ¼ 21. Bar ¼ 250 mm. DAF-FM, diaminofluorescein-FM; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MMP14, matrix metalloproteinase 14; NO, nitric oxide.
    Human Enos Nos3 Small Interfering Rna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+enos+nos3+small+interfering+rna/NOS3+siRNA/pm34968503-199-21-28
    Average 90 stars, based on 6 article reviews
    human enos nos3 small interfering rna - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Loss of Endothelial Cell Matrix Metalloproteinase 14 Reduces Melanoma Growth and Metastasis by Increasing Tumor Vessel Stability."

    Article Title: Loss of Endothelial Cell Matrix Metalloproteinase 14 Reduces Melanoma Growth and Metastasis by Increasing Tumor Vessel Stability.

    Journal: The Journal of investigative dermatology

    doi: 10.1016/j.jid.2021.12.016

    Figure 6. eNOS expression and NO production in EC. (a) Analysis of DAF-FM fluorescence intensity of primary ECs measured at 495 nm. Scatter dot plot shows the mean SD; n ¼ 3. **P < 0.005. (b) NOS3 transcript amplification in primary ECs of Mmp14fl/fland Mmp14EC‒/‒ mice using S26 as control. Scatter dot plot shows the mean SD; n ¼ 9; *P < 0.05. (c) Primary ECs stained for eNOS (red) and nuclei (DAPI, blue). eNOS expression intensity was quantified. The scatter dot plot shows the mean SD. **P < 0.005. Bar ¼ 50 mm. (d) Quantitative analysis of eNOS and MMP14 expression in human melanoma. Intensities are arbitrarily set as þ (low), þþ (moderate), and þþþ (high). Graphs show the percentage of eNOS expression intensity in low, moderate, or high MMP14- expressing vessels. Arrowheads indicate representative vessels. n ¼ 21. Bar ¼ 250 mm. DAF-FM, diaminofluorescein-FM; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MMP14, matrix metalloproteinase 14; NO, nitric oxide.
    Figure Legend Snippet: Figure 6. eNOS expression and NO production in EC. (a) Analysis of DAF-FM fluorescence intensity of primary ECs measured at 495 nm. Scatter dot plot shows the mean SD; n ¼ 3. **P < 0.005. (b) NOS3 transcript amplification in primary ECs of Mmp14fl/fland Mmp14EC‒/‒ mice using S26 as control. Scatter dot plot shows the mean SD; n ¼ 9; *P < 0.05. (c) Primary ECs stained for eNOS (red) and nuclei (DAPI, blue). eNOS expression intensity was quantified. The scatter dot plot shows the mean SD. **P < 0.005. Bar ¼ 50 mm. (d) Quantitative analysis of eNOS and MMP14 expression in human melanoma. Intensities are arbitrarily set as þ (low), þþ (moderate), and þþþ (high). Graphs show the percentage of eNOS expression intensity in low, moderate, or high MMP14- expressing vessels. Arrowheads indicate representative vessels. n ¼ 21. Bar ¼ 250 mm. DAF-FM, diaminofluorescein-FM; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MMP14, matrix metalloproteinase 14; NO, nitric oxide.

    Techniques Used: Expressing, Control, Staining

    Related Articles

    Transfection:

    Article Title: Loss of Endothelial Cell Matrix Metalloproteinase 14 Reduces Melanoma Growth and Metastasis by Increasing Tumor Vessel Stability.
    Article Snippet: The small interfering RNA used for mouse eNOS (NOS3) was from Santa Cruz Biotechnology (Heidelberg, Germany) (sc36094). .. Human umbilical vein endothelial cells were transfected with 10 nM human MMP14 small interfering RNA (Ambion, 8877, Thermo Fisher Scientific) and human eNOS (NOS3) small interfering RNA (sc-36093, Santa Cruz Biotechnology). ..

    Small Interfering RNA:

    Article Title: Loss of Endothelial Cell Matrix Metalloproteinase 14 Reduces Melanoma Growth and Metastasis by Increasing Tumor Vessel Stability.
    Article Snippet: The small interfering RNA used for mouse eNOS (NOS3) was from Santa Cruz Biotechnology (Heidelberg, Germany) (sc36094). .. Human umbilical vein endothelial cells were transfected with 10 nM human MMP14 small interfering RNA (Ambion, 8877, Thermo Fisher Scientific) and human eNOS (NOS3) small interfering RNA (sc-36093, Santa Cruz Biotechnology). ..



    Similar Products

    human enos nos3 small interfering rna  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology human enos nos3 small interfering rna
    Figure 6. <t>eNOS</t> expression and NO production in EC. (a) Analysis of DAF-FM fluorescence intensity of primary ECs measured at 495 nm. Scatter dot plot shows the mean SD; n ¼ 3. **P < 0.005. (b) <t>NOS3</t> transcript amplification in primary ECs of Mmp14fl/fland Mmp14EC‒/‒ mice using S26 as control. Scatter dot plot shows the mean SD; n ¼ 9; *P < 0.05. (c) Primary ECs stained for eNOS (red) and nuclei (DAPI, blue). eNOS expression intensity was quantified. The scatter dot plot shows the mean SD. **P < 0.005. Bar ¼ 50 mm. (d) Quantitative analysis of eNOS and MMP14 expression in human melanoma. Intensities are arbitrarily set as þ (low), þþ (moderate), and þþþ (high). Graphs show the percentage of eNOS expression intensity in low, moderate, or high MMP14- expressing vessels. Arrowheads indicate representative vessels. n ¼ 21. Bar ¼ 250 mm. DAF-FM, diaminofluorescein-FM; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MMP14, matrix metalloproteinase 14; NO, nitric oxide.
    Human Enos Nos3 Small Interfering Rna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+enos+nos3+small+interfering+rna/NOS3+siRNA/pm34968503-199-21-28
    Average 90 stars, based on 1 article reviews
    human enos nos3 small interfering rna - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 6. eNOS expression and NO production in EC. (a) Analysis of DAF-FM fluorescence intensity of primary ECs measured at 495 nm. Scatter dot plot shows the mean SD; n ¼ 3. **P < 0.005. (b) NOS3 transcript amplification in primary ECs of Mmp14fl/fland Mmp14EC‒/‒ mice using S26 as control. Scatter dot plot shows the mean SD; n ¼ 9; *P < 0.05. (c) Primary ECs stained for eNOS (red) and nuclei (DAPI, blue). eNOS expression intensity was quantified. The scatter dot plot shows the mean SD. **P < 0.005. Bar ¼ 50 mm. (d) Quantitative analysis of eNOS and MMP14 expression in human melanoma. Intensities are arbitrarily set as þ (low), þþ (moderate), and þþþ (high). Graphs show the percentage of eNOS expression intensity in low, moderate, or high MMP14- expressing vessels. Arrowheads indicate representative vessels. n ¼ 21. Bar ¼ 250 mm. DAF-FM, diaminofluorescein-FM; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MMP14, matrix metalloproteinase 14; NO, nitric oxide.

    Journal: The Journal of investigative dermatology

    Article Title: Loss of Endothelial Cell Matrix Metalloproteinase 14 Reduces Melanoma Growth and Metastasis by Increasing Tumor Vessel Stability.

    doi: 10.1016/j.jid.2021.12.016

    Figure Lengend Snippet: Figure 6. eNOS expression and NO production in EC. (a) Analysis of DAF-FM fluorescence intensity of primary ECs measured at 495 nm. Scatter dot plot shows the mean SD; n ¼ 3. **P < 0.005. (b) NOS3 transcript amplification in primary ECs of Mmp14fl/fland Mmp14EC‒/‒ mice using S26 as control. Scatter dot plot shows the mean SD; n ¼ 9; *P < 0.05. (c) Primary ECs stained for eNOS (red) and nuclei (DAPI, blue). eNOS expression intensity was quantified. The scatter dot plot shows the mean SD. **P < 0.005. Bar ¼ 50 mm. (d) Quantitative analysis of eNOS and MMP14 expression in human melanoma. Intensities are arbitrarily set as þ (low), þþ (moderate), and þþþ (high). Graphs show the percentage of eNOS expression intensity in low, moderate, or high MMP14- expressing vessels. Arrowheads indicate representative vessels. n ¼ 21. Bar ¼ 250 mm. DAF-FM, diaminofluorescein-FM; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MMP14, matrix metalloproteinase 14; NO, nitric oxide.

    Article Snippet: Human umbilical vein endothelial cells were transfected with 10 nM human MMP14 small interfering RNA (Ambion, 8877, Thermo Fisher Scientific) and human eNOS (NOS3) small interfering RNA (sc-36093, Santa Cruz Biotechnology).

    Techniques: Expressing, Control, Staining